Recently, Holm et al. demonstrated that CD44 was upregulated during CML blast crisis transformation and CD44 inhibition reduced blast crisis leukemia stem cell self-renewal29. This evidence concerns the gene CD44 and chronic myelogenous leukemia, BCR-ABL1 positive.